Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells

Blood

Volumn 104, Issue 3, 2004, Pages 768-774

  Tanaka, Junji ^a   Toubai, Tomomi ^a   Tsutsumi, Yutaka ^a   Miura, Yoko ^a   Kato, Naoko ^a   Umehara, Shintarou ^a   Kahata, Kaoru ^a   Mori, Akio ^a   Toyoshima, Nobuyasu ^a   Ota, Shuichi ^a   Kobayashi, Takahiko ^a   Kobayashi, Masanobu ^a   Kasai, Masaharu ^a   Asaka, Masahiro ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CYTOKINE RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; INTERLEUKIN 12; INTERLEUKIN 15; MONOCLONAL ANTIBODY CD3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; PHYTOHEMAGGLUTININ; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN K 562; COLON CANCER; CONTROLLED STUDY; CYTOLYSIS; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MIXED LYMPHOCYTE CULTURE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCID MOUSE; SOLID TUMOR; T LYMPHOCYTE;

EID: 3242800538     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-11-3870     Document Type: Article

References (34)

1. Ljunggren HG, Karre K. In search of the "missing self: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244.
2. Moretta A, Biassoni R, Bottino C, et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 1997;155:105-117.
3. Bakker ABH, Phillips JH, Figdor CG, Lanier LL. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL. J Immunol. 1998;160:5239-5245.
4. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 1995;268:403-405.
5. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A. 1996;93:12433-12438.
6. + T cells is controlled by T-cell receptor engagement. Nature. 2000;403:325-328.
7. + T cells. Proc Natl Acad Sci U S A. 1998;95:1172-1177.
8. + T cells expressing NK receptors for major histocompatibility complex class I after "Three-Loci" HLA-incompatible bone marrow transplantation. Blood. 1996;87:3993-4000.
9. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94:333-339.
10. Cambiaggi A, Verthuy C, Naquet P, et al. Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD158b). Proc Natl Acad Sci U S A. 1997;94:8088-8092.
11. Cambiaggi A, Darche S, Guia S, Kourilsky P, Abastado JP, Vivier E. Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice. Blood. 1999;94:2396-2402.
12. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097-2100.
13. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants: killer immunoglobulin-like receptor. Blood. 2002;100:3825-3827.
14. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 2003;102:814-819.
15. Braud VM, Allan DSJ, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391:795-799.
16. Tanaka J, Mori A, Ohta S, et al. Expression of HLA-C specific natural killer cell receptor (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation. Br J Haematol. 2000;108:778-783.
17. Tanaka J, Mori A, Ohta S, Kobayashi S, Asaka M, Imamura M. Sequential analysis of HLA-C specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease. Bone Marrow Transplant. 2000;26:287-290.
18. Tanaka J, Tsutsumi Y, Zhang L, et al. Increased expression of HLA-class I-specific killer cell inhibitory receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation. Acta Haematol. 2001;105:89-91.
19. + cells from G-CSF-mobilized peripheral blood mononuclear cells. Br J Haematol. 2002;117:751-754.
20. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T cells: a safe mechanism that may impair protective T-cell responses. Immunol Today. 1998;19:153-157.
21. Lowdell MW, Lamb L, Hoyle C, Velardi A, Prentice HG. Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias. Br J Haematol. 2001;114:11-24.
22. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caliggiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood. 2002;100:1935-1947.
23. Blaise D, Kuentz M, Fortanier C, et al. Randomized trial of bone marrow versus lenograstim-primed blood cell transplantation in patients with early-stage leukemia: a report from the Societe de Greffe de Moelle. J Clin Oncol. 2000;18:537-546.
24. Powles R, Mehta J, Kulkarni S, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomized trial. Lancet. 2000;355:1231-1237.
25. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344:175-181.
26. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood. 1997;89:1629-1634.
27. Mielcarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood. 1998;92:215-222.
28. Tanaka J, Mielcarek M, Torok-Storb B. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood. 1998;91:347-352.
29. Ulbrecht M, Honka T, Person S, Johnson JP, Weiss EH. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol. 1992;149:2945-2953.
30. Tsutsumi Y, Tanaka J, Sugita J, et al. Analysis of T cell repertoire and mixed chimerism in a patient with aplastic anemia after allogeneic bone marrow transplantation. Br J Haematol. 2002;118:136-139.
31. Borrego F, Ulbrech M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLAS class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 1998;187:813-818.
32. Derre L, Corvaisier M, Pandolfino MC, Diaz E, Jotereau, F, Gervois N. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy. J Immunol. 2002;168:4864-4870.
33. Beresford PJ, Xia Z, Greenberg AH, Lieberman J. Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. Immunity. 1999;10:585-594.
34. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002;419:734-738.